Overview
- 88 inspections across 84 sites are on record.
- 186 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-10-14.
At a glance
Inspections
88
Sites
84
Observations
186
Career since
Feb 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED | 14 Oct 2022 | Human Drugs | |
| Canadian Custom Packaging Co. | 31 Jan 2020 | Human Drugs | View 483 → |
| Laboratoires Delon | 24 Jan 2020 | Human Drugs | View 483 → |
| Delpharm Montreal Inc. | 17 Jan 2020 | Human Drugs | |
| Juzen Chemical Corporation | 7 Nov 2019 | Human Drugs |
Sites inspected
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITEDDublin 15, Ireland1 insp.
Canadian Custom Packaging Co.North York, Canada1 insp.
Laboratoires DelonPointe-Claire, Canada1 insp.
Delpharm Montreal Inc.Pointe-Claire, Canada1 insp.
Juzen Chemical CorporationToyama, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Anastasia M Shields4 shared
Patric C Klotzbuecher4 shared
Eric J Reisenauer4 shared
Charanjeet Jassal3 shared
Sony Mathews3 shared
Arsen Karapetyan2 shared
Yvonne M Santiago2 shared
Charisse K Green2 shared
Mindy M Chou2 shared
Jose O Hernandez1 shared
Full investigator report
Get the verbatim findings behind Samina S Khan's 186 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site